Skip to main content
Clinical Epigenetics logoLink to Clinical Epigenetics
. 2019 Oct 21;11:144. doi: 10.1186/s13148-019-0737-7

Correction to: DNA methylation signature is prognostic of choroid plexus tumor aggressiveness

Malgorzata Pienkowska 1, Sanaa Choufani 1, Andrei L Turinsky 1,2, Tanya Guha 1, Diana M Merino 3, Ana Novokmet 1, Michael Brudno 1,2,4, Rosanna Weksberg 1,5,8, Adam Shlien 1,6, Cynthia Hawkins 1,6, Eric Bouffet 7,8, Uri Tabori 1,7,8, Richard J Gilbertson 10, Jonathan L Finlay 11, Nada Jabado 12, Christian Thomas 13, Martin Sill 14,15, David Capper 16,17, Martin Hasselblatt 13, David Malkin 1,7,8,9,
PMCID: PMC6802296  PMID: 31639040

Correction to: Clin Epigenetics

https://doi.org/10.1186/s13148-019-0708-z

After publication of the original article [1], authors have requested to add a ‘J’ as middle name for Richard Gilbertson. Hence, full name should be Richard J Gilbertson.

The original article has been corrected.

The publisher apologies for the inconvenience.

Footnotes

Ana Novokmet is deceased. This paper is dedicated to his memory.

Reference

  • 1.Pienkowska M, et al. DNA methylation signature is prognostic of choroid plexus tumor aggressiveness. Clin Epigenetics. 2019;11:117. doi: 10.1186/s13148-019-0708-z. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical Epigenetics are provided here courtesy of BMC

RESOURCES